v3.26.1
Consolidated Balance Sheets - USD ($)
$ in Millions
Mar. 31, 2026
Jun. 30, 2025
Current assets:    
Cash and cash equivalents $ 3,228.4 $ 3,347.8
Short-term marketable securities [1] 0.0 4,498.8
Accounts receivable, net of allowance for doubtful accounts of $46.0 and $47.1, respectively 3,569.2 3,579.1
Other current assets 1,023.4 840.8
Total current assets before funds held for clients 7,821.0 12,266.5
Funds held for clients 46,413.1 30,985.7
Total current assets 54,234.1 43,252.2
Property, plant and equipment, net 622.7 655.4
Operating lease right-of-use asset 400.8 374.1
Deferred contract costs 3,137.9 3,154.1
Other assets 1,159.0 1,057.0
Goodwill 3,289.1 3,273.5
Intangible assets, net 1,640.6 1,603.0
Total assets 64,484.2 53,369.3
Current liabilities:    
Accounts payable 136.1 169.1
Accrued expenses and other current liabilities 3,013.1 3,092.4
Accrued payroll and payroll-related expenses 777.9 973.1
Dividends payable 676.8 620.6
Short-term deferred revenues 269.1 262.8
Obligations under reverse repurchase agreements [1] 0.0 38.4
Obligations under commercial paper borrowings 0.0 4,769.5
Income taxes payable 372.2 9.1
Total current liabilities before client funds obligations 5,245.2 9,935.0
Client funds obligations 46,774.5 31,343.3
Total current liabilities 52,019.7 41,278.3
Long-term debt 3,977.3 3,974.7
Operating lease liabilities 318.2 321.2
Other liabilities 1,089.1 1,058.3
Deferred income taxes 344.9 163.6
Long-term deferred revenues 384.9 385.2
Total liabilities 58,134.1 47,181.3
Commitments and contingencies (Note 14)
Stockholders' equity:    
Preferred stock, $1.00 par value: authorized, 0.3 shares; issued, none 0.0 0.0
Common stock, $0.10 par value: authorized, 1,000.0 shares; issued, 638.7 shares at March 31, 2026 and June 30, 2025; outstanding, 400.6 and 405.3 shares at March 31, 2026 and June 30, 2025, respectively 63.9 63.9
Capital in excess of par value 3,012.7 2,788.3
Retained earnings 26,668.1 25,240.6
Treasury stock - at cost: 238.1 and 233.4 shares at March 31, 2026 and June 30, 2025, respectively (22,541.5) (21,021.4)
Accumulated other comprehensive income/(loss) (853.1) (883.4)
Total stockholders’ equity 6,350.1 6,188.0
Total liabilities and stockholders’ equity $ 64,484.2 $ 53,369.3
[1] As of June 30, 2025, $38.4 million of short-term marketable securities have been pledged as collateral under the Company's reverse repurchase agreements (see Note 10).